Citing a McKinsey study, he said in the demand for global sterile vials, “there’s a delta between demand and supply of approximately 700 million units. So 6.8 billion is demand, 6.1 million supply”, and two years ago, there was a big push in the US and a lot of companies consolidated and converted the capacities to pre-filled syringes.
